Graves' hyperthyroidism: Treatment with antithyroid drugs, surgery, or radioiodine - A prospective, randomized study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 2986-2993

  Törring, Ove ^a   Tallstedt, Leif ^a   Wallin, Göran ^a   Lundell, Göran ^a   Ljunggren, Jan Gustaf ^b   Taube, Adam ^c   Sääf, Maria ^a   Hamberger, Bertil ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; LIOTHYRONINE; LUGOL; METOPROLOL; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ABSENTEEISM; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SUBTOTAL THYROIDECTOMY; TREATMENT OUTCOME;

EID: 0029788195     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.2986     Document Type: Article

References (42)

1. Glinoer D, Hesch D, Lagasse R, Laurberg P. 1987 The management of hyperthyroidism due to Graves' disease in Europe 1986. Results of an international survey. Acta Endocrinol (Copenh). 285(Suppl):5-23.
2. Solomon B, Glinoer D, Lagasse R, Wartofsky L. 1990 Current trends in the management of Graves' disease. J Clin Endocrinol Metab. 70:1518-1524.
3. Wartofsky L, Glinoer D, Solomon B, Lagasse R. 1991 Differences and similarities in the treatment of diffuse goiter in Europe and the United States. Exp Clin Endocrinol. 97:243-251.
4. Ford HC, Delahunt JW, Feek CM. 1991 The management of Graves' disease in New Zealand: results of a national survey. NZ Med J. 104:251-252.
5. Nagayama Y, Izumi M, Nagataki S. 1989 The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association. Endocrinol Jpn. 36:299-314.
6. Tunbridge WMG, Evered DC, Hall R, et al. 1977 The spectrum of thyroid disease in a community, the Whickham survey. Clin Endocrinol (Oxf). 7:481-493.
7. Petersen K, Lindstedt G, Lundberg P-A, Bengtsson C, Lapidus L, Nystrom E. 1991 Thyroid disease in middle-aged and elderly Swedish women: thyroid related hormones, thyroid dysfunction and goitre in relation to age and smoking. J Intern Med. 229:407-414.
8. Tallstedt L, Lundell G, Törring O, et al. 1991 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med. 326:1733-1738.
9. Larsson L-G. 1955 Studies on radioiodine treatment of thyrotoxicosis: with special reference to the behavior of the radioiodine tracer tests. Acta Radiol. 126(Suppl):1-164.
10. Davies TF, Yeo PPB, Evered DC, Clark F, Rees Smith B, Hall R. 1977 Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. Lancet. 1:1181-1182.
11. McGregor AM, Rees Smith B, Hall R, Petersen MM, Miller M, Dewar PJ. 1980 Prediction of relapse in hyperthyroid Graves' disease. Lancet. 1:1101-1103.
12. Teng CS, Yeung RTT. 1980 Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study. J Clin Endocrinol Metab. 50:144-147.
13. Hardisty CA, Hanford L, Munro DS. 1981 The prediction of relapse after drug treatment of Graves' disease by assay of long acting thyroid stimulator-protector (LATS-P). Clin Endocrinol (Oxf). 14:509-517.
14. Madec AM, Laurent MC, Lorcy Y, et al. 1984 Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease? Clin Endocrinol (Oxf). 21:247-255.
15. Tötterman TH, Karlsson FA, Bengtsson M, Mendel-Hartvig I. 1987 Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves's disease. N Engl J Med. 316:15-22.
16. Orgiazzi J. 1987 Management of Graves' hyperthyroidism. Endocrinol Metab Clin North Am. 16:365-388.
17. Allannic H, Fauchet R, Orgiazzi J, et al. 1990 Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab. 70:675-69.
18. Tamai H, Nakagawa T, Fukino O, et al. 1980 Thionamide therapy in Graves' disease: relation of relapse to du ration of therapy. Ann Intern Med. 92:488-490.
19. Romaldini JH, Bromberg N, Werner RS, et al. 1983 Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. J Clin Endocrinol Metab. 57:563-570.
20. Reinwein D, Benker G, Lazarus JH, Alexander WD, European Multicenter Study Group on Antithyroid Drug Treatment. 1993 A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. J Clin Endocrinol Metab. 76:1516.
21. Berglund J, Chrislensen SB, Dymling JF, Hallengren B. 1991 The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmö during the period 1970-1974. J Intern Med. 229:435-442.
22. Winsa B, Dahlberg A, Jansson R, Ågren H, Karlsson FA. 1990 Factors influencing the outcome of thyrostatic drug therapy in Graves' disease. Acta Endocrinol (Copenh). 122:722-728.
23. Mori Y, Matoba N, Miura S, Sakai S, Taira Y. 1992 Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease. World J Surg. 16:647-653.
24. Okamoto T, Fujimoto Y, Obara T, Ito Y, Aiba M. 1992 Retrospective analysis of prognostic factors affecting the thyroid function status after subtotal thyroidectomy for Graves' disease. World J Surg. 16:690-696.
25. Menegaux F, Ruprecht T, Chigot J-P. 1993 The surgical treatment of Graves' disease. Surg Gynecol Obstet. 176:277-282.
26. Sugrue D, McEvoy M, Feely J, Drury MI. 1980 Hyperthyroidism in the land of Graves-results of treatment by surgery, radioiodine and carbimazole in 837 cases. Q J Med. 49:51-61.
27. Röher H-D, Horster FA, Frilling A, Goretzki PE, Witte J. 1991 Surgery for immunogenic hyperthyroidism. Exp Clin Endocrinol. 97:292-296.
28. Andåker L, Johansson K, Smeds S, Lennquist S. 1992 Surgery for hyperthyroidism: hemithyroidectomy plus contralateral resection or bilateral resection? A prospective randomized study of postoperative complications and long-term results. World J Surg. 16:765-769.
29. Tallstedt L, Lundell G, Blomgren H, Bring J. 1994 Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol. 130:494-497.
30. Nofal MM, Beierwaltes WH, Patno ME. 1966 Treatment of hyperthyroidism with sodium iodide 1-131. JAMA. 197:605-610.
31. Douglas JG. 1973 The Vanderbilt experience with 1-131 treatment for Graves' disease. South Med J. 66:92-94.
32. Holm L-E, Lundell G, Israelsson A, Dahlqvist I. 1982 Incidence of hypothy roiclism occurring long after iodine-131 therapy for hyperthyroidism. J Nucl Med. 23:103-107.
33. Holm L-E. 1982 Changing annual incidence of hypothyroidism after iodine-131 therapy for hyperthyroidism, 1951-1975. J Nucl Med. 23:108-112.
34. 131I therapy for Graves' disease. N Engl J Med. 311:426-432.
35. 131I treatment of hyperthyroidism. Ann Intern Med. 76:721-723.
36. McGregor AM, Petersen MM, Capiferri R, Evered DC, Rees Smith B, Hall R. 1979 Effects of radioiodine on thyrotropin binding inhibiting immunoglobulins in Graves' disease. Clin Endocrinol (Oxf). 11:437-444.
37. Hardisty CA, Fowles A, Munro DS. 1984 The effect of radioiodine and antithyroid drugs on serum long acting thyroid stimulator protector (LATS-P). A three year prospective study. Clin Endocrinol (Oxf). 20:597-605.
38. Bech K, Nistrup Madsen S. 1980 Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease. Clin Endocrinol (Oxf) 13:417-424.
39. 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease. J Clin Endocrinol Metab. 62:773-777.
40. Almqvist S, Algvere P. 1972 Hypothyroidism in progressive ophthalmopathy in Graves' disease. Acta Ophthalmol (Copenh). 50:761-770.
41. Karlsson FA, Dahlberg PA, Jansson R, Westermark K, Enoksson P. 1989 Importance of TSH receptor activation in the development of severe endocrine ophthalmopathy. Acta Endocrinol (Copenh). 121(Suppl 2):132-141.
42. Sjöberg HE, Sääf M, Boström L, Lundell G, Tallstedt L. 1989 Observations on progress periods in Graves' ophthalmopathy. Acta Endocrinol (Copenh). 121(Suppl 2):179-181.